Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 45

Sort by

Sort Order Select

Journal Articles

Distinct Effects of Chondroitin Sulfate on Hematopoietic Cells and the Stromal Microenvironment in Bone Marrow Hematopoiesis

Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Asami Kawasaki, PhD, Shun Uemura, MD, Tatsuya Suwabe, MD, Tomoyuki Tanaka, MD PhD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD, Hirohito Sone, MD PhD, Michihiro Igarashi, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 3852.

https://doi.org/10.1182/blood-2018-99-115796

Published: 2018

Journal Articles

Disruption of NOTCH1-MYC-CD44 Axis Targets Leukemia Initiating Cells (LIC) in T-ALL

Sujan Piya, PhD, Seemana Bhattacharya, PhD, Hong Mu, MD PhD, Vivian Ruvolo, MS, Natalia Baran, PhDMD, Teresa McQueen, MS, R. Eric Davis, MD, Yimin Qian, PhD, Kanak Raina, PhD, M. James You, MD PhD, Marina Y. Konopleva, MD PhD, Hagop M. Kantarjian, MD, Michael Andreeff, MD PhD, Gautam Borthakur, MD

Blood (2018) 132 (Supplement 1): 890.

https://doi.org/10.1182/blood-2018-99-115692

Published: 2018

Journal Articles

Recreating the Hematopoietic Microenvironment in Vitro Using Microfluidic “on-a-Chip” Technology Enables the Study of Interactions of Normal and Malignant HSPC with Specific Bone Marrow Niches

Sunil George, PhD, Julio Aleman, MS, M. Graca Almeida-Porada, MD PhD, Aleksander Skardal, PhD, Christopher D Porada, PhD

Blood (2017) 130 (Supplement 1): 3779.

https://doi.org/10.1182/blood.V130.Suppl_1.3779.3779

Published: 2017

Journal Articles

Evaluation of Endothelial Damage in Sinusoidal Obstructive Syndrome

Nora Butta, PhD, Carmen de Ramón, MD, Raul Justo Sanz, BS Pharm, Elena Monzon Manzano, BSBC, Ihosvany Fernandez Bello, PhD, Mercedes Gasior, MD, Raquel De Paz, PhD, Karem Humala, MD, Pilar Gomez, MD, Ana Lopez de la Guia, MD, Marta Fabra, MD, Miguel Canales, MD PhD, Victor Jiménez Yuste, PhD

Blood (2016) 128 (22): 5802.

https://doi.org/10.1182/blood.V128.22.5802.5802

Published: 2016

Journal Articles

Proteomic Characterization of Circulating Extracellular Vesicles Identifies Novel Serum Myeloma Associated Markers

David Ciarlariello, Sean Harshman, Alessandro Canella, Erinn Hade, Alberto Rocci, MD, Antonio Palumbo, MD, Craig C Hofmeister, MD MPH, Michael Freitas, Don M Benson, MD PhD, Flavia Pichiorri, PhD

Blood (2015) 126 (23): 1814.

https://doi.org/10.1182/blood.V126.23.1814.1814

Published: 2015

Journal Articles

Netrin-1 Promotes Osteoclast Activity in Multiple Myeloma Under Hypoxic Conditions: Modulation By a RANKL Inhibitor

Narayanan Bhagavathi, PhD, Blau Talia, BA, Nicole Adell Doudican, PhD, Narayanan Narayanan, PhD, Amitabha Mazumder, MD

Blood (2015) 126 (23): 1781.

https://doi.org/10.1182/blood.V126.23.1781.1781

Published: 2015

Journal Articles

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

Christen L Mumaw, BS, Ayman Akil, PhD, Nieves Velez de Mendizabal, PhD, Qing Zhang, Nisha Raiker, BS, Jeffrey Yu, Maribel Diaz-Ricart, PhD, Enric Carreras, MD, Laura S. Haneline, MD, Kent A. Robertson, MD PhD, Lindsey Elmore, Rose Case, Jamie Renbarger, MD, Samir Hanash, MD PhD, Robert R. Bies, PhD, Sophie Paczesny, MD PhD

Blood (2014) 124 (21): 663.

https://doi.org/10.1182/blood.V124.21.663.663

Published: 2014

Journal Articles

The Role Of CD44 Isoform Expression In Niche Resident Chronic Myeloid Leukemia Stem Cell Evolution

Cayla Mason, BSc, Frida Holm, PhD, Eva Hellqvist, PhD, Christian Barrett, PhD, Kelly A Frazer, Ph.D., Anil Sadarangani, PhD, Catriona HM Jamieson, MD, PhD

Blood (2013) 122 (21): 4028.

https://doi.org/10.1182/blood.V122.21.4028.4028

Published: 2013

Journal Articles

A6 Peptide Is Selectively Cytotoxic For Chronic Lymphocytic Leukemia Cells

Suping Zhang, PhD, Hsien Lai, BS, Grace Liu, Laura Rassenti, PhD, Michael Y. Choi, MD, Stephen B Howell, MD, Malcolm Finlayson, PhD, Thomas J. Kipps, MD, PhD

Blood (2013) 122 (21): 5303.

https://doi.org/10.1182/blood.V122.21.5303.5303

Published: 2013

Journal Articles

Resistance To Chemotherapy In Leukemia Cells Grown On An Extracellular Matrix-Based Leukemia Model Derived From Wharton’s Jelly

Dandan Li, Tara L. Lin, MD, Da Zhang, MD, Linheng Li, PhD, Richard A. Hopkins, Lisa Stehno-Bittel, PhD, Omar S. Aljitawi, MD

Blood (2013) 122 (21): 1388.

https://doi.org/10.1182/blood.V122.21.1388.1388

Published: 2013

Journal Articles

CD44 Monoclonal Antibody-Enhanced Clearance Of Chronic Myeloid Leukemia Stem Cells From The Malignant Niche

Eva Hellqvist, PhD, Frida Holm, PhD, Cayla N Mason, BS, Valeria Runza, Stefan Weigand, Anil Sadarangani, PhD, Catriona H.M. Jamieson, M.D., Ph.D.

Blood (2013) 122 (21): 858.

https://doi.org/10.1182/blood.V122.21.858.858

Published: 2013

Journal Articles

Triggering of CD44 by Ultra-Low-Molecular-Weight Hyaluronan Induces Cell Death by Autophagy Via Endoplasmic Reticulum Stress in Acute Lymphoblastic Leukemia with MLL Gene Rearrangements

Shin Kasai, Yoshiyuki Furuichi, MD, PhD, Norie Ando, Keiko Kagami, Kumiko Goi, MD, PhD, Takeshi Inukai, MD, PhD, Kanji Sugita, MD, PhD

Blood (2012) 120 (21): 1361.

https://doi.org/10.1182/blood.V120.21.1361.1361

Published: 2012

Journal Articles

Gelatinous transformation

Claudiu V. Cotta

Blood (2012) 120 (11): 2166.

https://doi.org/10.1182/blood-2012-02-408815

Published: 2012

Journal Articles

A Monoclonal Antibody Specifically Targeting CD44 Inhibits B-Cell Chronic Lymphocytic Leukemia Cell Survival In Vitro and In Vivo

Suping Zhang, PhD, Christina C.N. Wu, Ph.D., Jessie-Farah Fecteau, Ph.D., Bing Cui, PhD, Rongrong Wu, Laura Z. Rassenti, Ph.D., Fitzgerald S. Lao, B.S., Rommel Tawatao, B.S., Stefan Weigland, PhD, Charles Prussak, PhD, Dennis A. Carson, MD, Thomas J. Kipps, M.D., Ph.D

Blood (2011) 118 (21): 927.

https://doi.org/10.1182/blood.V118.21.927.927

Published: 2011

Journal Articles

Innovative blood vessels bring new life

Edward K. Geissler, Peter Angele

Blood (2011) 118 (3): 488–490.

https://doi.org/10.1182/blood-2011-05-352609

Published: 2011

Journal Articles

HYC750: A Novel Stem Cell Mobilizer.

Brett Schönekess, Rosalia De Necochea Campion, MSc, Victoria Dardov, Srdjan Sonjara, Steven F. Josephs, PhD, Famela Ramos, Thomas Ichim, Boris Minev, MD, Ewa Carrier, MD

Blood (2009) 114 (22): 3220.

https://doi.org/10.1182/blood.V114.22.3220.3220

Published: 2009

Journal Articles

Identification of RHAMM-Derived CD8 + Restricted, Heteroclitical, Cryptic Epitope R9Y as a Promising Target for Immunotherapy of Chronic Lymphocytic Leukemia.

Krzysztof Giannopoulos, Anna Dmoszynska, Jacek Rolinski, Jochen Greiner, Stephan Stilgenbauer, Michael Schmitt

Blood (2009) 114 (22): 3034.

https://doi.org/10.1182/blood.V114.22.3034.3034

Published: 2009

Journal Articles

Peptide Vaccination Induces Dynamic Changes in CD4+ and CD8+ T Cell Subsets: Report on the First Peptide Vaccination Trial in Patients with Chronic Lymphocytic Leukemia (CLL)

Krzysztof Giannopoulos, MD, PhD, Malgorzata Kowal, Anna Dmoszynska, MD, PhD, Jacek Rolinski, Kamila Mazurek, Jochen Greiner, Markus Rojewski, Stephan Stilgenbauer, Hartmut Döhner, Michael Schmitt

Blood (2008) 112 (11): 3159.

https://doi.org/10.1182/blood.V112.11.3159.3159

Published: 2008

Journal Articles

CD44 Signaling Via PI3K/AKT and MAPK/ERK Pathways Protects CLL Cells from Spontaneous and Drug Induced Apoptosis

Yair Herishanu, MD, Federica Gibellini, PhD, Ndegwa Njuguna, MD, Keyvan Keyvanfar, BS, Adrian Wiestner, MD, PhD

Blood (2008) 112 (11): 541.

https://doi.org/10.1182/blood.V112.11.541.541

Published: 2008

Journal Articles

Hyaluronidase and IFN-γ from Activated T-Cells Are Key Mediators To Induce Immunosuppressive Activity of Mesenchymal Stem Cells.

Kazuya Sato, MD, PhD, Ozaki Katsutoshi, MD., PhD., Iekuni Oh, MD., PhD., Haruko Matsu, MD., Raine Tatara, MD., Akiko Meguro, MD., Keiko Hatanaka, Tadashi Nagai, MD., PhD., Kazuo Muroi, MD., PhD, Keiya Ozawa, MD., PhD

Blood (2007) 110 (11): 3246.

https://doi.org/10.1182/blood.V110.11.3246.3246

Published: 2007

NARROW

Distinct Effects of Chondroitin Sulfate on Hematopoietic Cells and the Stromal Microenvironment in Bone Marrow Hematopoiesis

Disruption of NOTCH1-MYC-CD44 Axis Targets Leukemia Initiating Cells (LIC) in T-ALL

Recreating the Hematopoietic Microenvironment in Vitro Using Microfluidic “on-a-Chip” Technology Enables the Study of Interactions of Normal and Malignant HSPC with Specific Bone Marrow Niches

Evaluation of Endothelial Damage in Sinusoidal Obstructive Syndrome

Proteomic Characterization of Circulating Extracellular Vesicles Identifies Novel Serum Myeloma Associated Markers

Netrin-1 Promotes Osteoclast Activity in Multiple Myeloma Under Hypoxic Conditions: Modulation By a RANKL Inhibitor

Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation

The Role Of CD44 Isoform Expression In Niche Resident Chronic Myeloid Leukemia Stem Cell Evolution

A6 Peptide Is Selectively Cytotoxic For Chronic Lymphocytic Leukemia Cells

Resistance To Chemotherapy In Leukemia Cells Grown On An Extracellular Matrix-Based Leukemia Model Derived From Wharton’s Jelly

CD44 Monoclonal Antibody-Enhanced Clearance Of Chronic Myeloid Leukemia Stem Cells From The Malignant Niche

Triggering of CD44 by Ultra-Low-Molecular-Weight Hyaluronan Induces Cell Death by Autophagy Via Endoplasmic Reticulum Stress in Acute Lymphoblastic Leukemia with MLL Gene Rearrangements

Gelatinous transformation

A Monoclonal Antibody Specifically Targeting CD44 Inhibits B-Cell Chronic Lymphocytic Leukemia Cell Survival In Vitro and In Vivo

Innovative blood vessels bring new life

HYC750: A Novel Stem Cell Mobilizer.

Identification of RHAMM-Derived CD8 + Restricted, Heteroclitical, Cryptic Epitope R9Y as a Promising Target for Immunotherapy of Chronic Lymphocytic Leukemia.

Peptide Vaccination Induces Dynamic Changes in CD4+ and CD8+ T Cell Subsets: Report on the First Peptide Vaccination Trial in Patients with Chronic Lymphocytic Leukemia (CLL)

CD44 Signaling Via PI3K/AKT and MAPK/ERK Pathways Protects CLL Cells from Spontaneous and Drug Induced Apoptosis

Hyaluronidase and IFN-γ from Activated T-Cells Are Key Mediators To Induce Immunosuppressive Activity of Mesenchymal Stem Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only